East Ocyon Bio

Gurugram, India Founded: 2022 • Age: 4 yrs
Developer of cell and gene therapies for the treatment of cancer

About East Ocyon Bio

East Ocyon Bio is a Healthcare company based in Gurugram (India) founded in 2022 by Narinder Mehra, Dinesh Kundu, and Renu Kundu. Developer of cell and gene therapies for the treatment of cancer. East Ocyon Bio has raised $4.2 million across 1 funding round from investors including Aeravti Ventures and Micro Labs. The company has 1 employees. Its Indian entity East Ocyon Bio Private Limited reported revenue of β‚Ή32.3 Lakh. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.

Company details

East Ocyon Bio was founded in 2022 in Gurugram, India, within the biotechnology sector. Allogeneic, off-the-shelf chimeric antigen receptor (CAR)-NK cell therapies are developed for cancer treatment, including solid tumors. Non-viral cell engineering technology and synthetic biology are employed to advance these therapies, focusing on accessible options for patients across various cancer types.

  • Headquarters Gurugram, India
  • Employees 1
  • Founders Narinder Mehra, Dinesh Kundu, Renu Kundu
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website eastocyonbio.com
  • Social LinkedIn X
  • Legal Name East Ocyon Bio Private Limited
  • Date of Incorporation 14 Mar, 2022
  • Jurisdiction Gurgaon, Haryana, India
Operational Areas
Key Metrics
  • Annual Revenue
    ₹32.3 Lakh

    FY 2025 · +1286% YoY

  • Net Loss
    -₹3.50 Cr

    FY 2025 · -1084% margin

  • EBITDA
    -₹3.15 Cr

    FY 2025 · -975% margin

  • Total Equity Funding
    $4.2M (USD)

    in 1 rounds

  • Latest Funding Round
    $4.2M (USD), Seed

    Dec 2024

  • Investors
  • Employee Count
    1

Funding Insights of East Ocyon Bio

East Ocyon Bio has successfully raised a total of $4.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $4.2 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.2M
  • Total Rounds 1
  • Last Round Seed β€” $4.2M
  • First Round $4.2M

    (Dec 2024)

  • Investors Count 2

All 1 funding rounds of East Ocyon Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2024$4.2MSeed–Aeravti Ventures, Micro Labs
–
Valuation history

2 investors in total: 2 institutional.

Investors in East Ocyon Bio

East Ocyon Bio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Aeravti Ventures and Micro Labs.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital firm investing in deep-tech, climate-tech, and agri-tech sectors with a focus on integrated bottom line values.
aeravti.comBengaluru, India
Generics and API manufacturer
microlabsltd.comBengaluru, India
Premium access

Investor details for East Ocyon Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of East Ocyon Bio Private Limited (East Ocyon Bio)

East Ocyon Bio Private Limited is the primary company behind East Ocyon Bio. The board of East Ocyon Bio Private Limited currently have 3 directors; the longest-serving is Renu, appointed in 2022. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Renu
DIN 07711725
Director14 Mar 20224 yrs 8 moEast Ocyon Bio Private Limited
Narinder Kumar Mehra
DIN 09535720
Director14 Mar 20224 yrs 8 moEast Ocyon Bio Private Limited
Dinesh Kundu
DIN 07291512
Director14 Mar 20224 yrs 8 moEast Ocyon Bio Private Limited

People of East Ocyon Bio

3 people are tracked at East Ocyon Bio (3 in leadership); the tracked headcount is 1.

NameRoleGroup
Co-Founder & DirectorLeadership
Co-Founder & DirectorLeadership
Renu Kundu
Co-Founder & DirectorLeadership
Premium access

Complete people profiles for East Ocyon Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of East Ocyon Bio

Figures of East Ocyon Bio Private Limited, the primary company behind East Ocyon Bio, for FY 2025. Revenue was ₹32.3 Lakh (+1286% year on year). Net loss was -₹3.50 Cr (-1084% margin). EBITDA was -₹3.15 Cr (-975% margin).

  • ₹32.3 LakhRevenue · FY 2025 · +1286% YoY
  • -₹3.50 CrNet loss · -1084% margin
  • -₹3.15 CrEBITDA · -975% margin
  • ₹4.97 CrPaid-up capital
  • 19Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of East Ocyon Bio Private Limited are on its company page.

Premium access

Detailed financial statements for East Ocyon Bio

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of East Ocyon Bio

2 dated milestones of East Ocyon Bio across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded East Ocyon Bio is founded.
  2. Funding First funding round of $4.2M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about East Ocyon Bio

Premium access

Complete news archive for East Ocyon Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about East Ocyon Bio

East Ocyon Bio was founded in 2022 and raised its 1st funding round 2 years after it was founded.

East Ocyon Bio is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

East Ocyon Bio is a funded company, having raised a total of $4.2M across 1 funding round to date. The company's 1st funding round was a Seed of $4.2M, raised on Dec 2024.

East Ocyon Bio has 1 employees.

The primary company behind East Ocyon Bio, East Ocyon Bio Private Limited, reported revenue of β‚Ή32.3 Lakh for FY 2025, up 1286% year on year.

East Ocyon Bio was founded in 2022 in Gurugram, India, within the biotechnology sector. Allogeneic, off-the-shelf chimeric antigen receptor (CAR)-NK cell therapies are developed for cancer treatment, including solid tumors. Non-viral cell engineering technology and synthetic biology are employed to advance these therapies, focusing on accessible options for patients across various cancer types.

East Ocyon Bio has 2 investors. Key investors include Aeravti Ventures, and Micro Labs.

East Ocyon Bio operates through East Ocyon Bio Private Limited.

The legal entities of East Ocyon Bio currently have 3 directors, including Renu, Narinder Kumar Mehra, Dinesh Kundu.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available